The Outcomes of Hypoglossal Nerve Stimulation in the Management of OSA: A systematic Review and Meta-analysis

Overview

Journal World J Otorhinolaryngol Head Neck Surg

Date 2019 Feb 19

PMID 30775701

Citations 15

Authors

Anvesh R Kompelli

Jonathan S Ni

Shaun A Nguyen

Eric J Lentsch

David M Neskey

Ted A Meyer

Affiliations

Soon will be listed here.

Abstract

Objectives: Obstructive sleep apnea (OSA) is a prevalent disease with significant health impacts. While first line therapy is CPAP, long-term compliance is low and device misuse is common, highlighting the need for alternative therapies. Upper airway surgery is one alternative, but substantial side effects hamper efficacy. A new alternative is an implantable hypoglossal nerve stimulator (HNS). These devices utilize neuromodulation to dilate/reinforce the airway and reduce side effects associated with traditional surgery. Several recent trials investigated the efficacy of these devices. The purpose of this study was to perform meta-analysis of available HNS studies investigating treatment of OSA to analyze objective and subjective outcomes and side effects.

Methods: A comprehensive literature search of PubMed and Scopus was performed. Two independent reviewers examined clinical trials investigating HNS in treatment of sleep apnea in adults. Studies with objective and subjective endpoints in sleep were included for analysis. Adverse events from trials were also recorded.

Results: Across 16 studies, 381 patients were analyzed. At 6 months ( = 0.008), mean SAQLI improved by 3.1 (95%, 2.6-3.7). At 12 months ( < 0.0001), mean AHI was reduced by 21.1 (95%, 16.9-25.3), mean ODI was reduced by 15.0 (95%, 12.7-17.4), mean ESS was reduced by 5.0 (95%, 4.2-5.8), mean FOSQ improved by 3.1 (95%, 2.6-3.4). Pain (6.2%:0.7-16.6), tongue abrasion (11.0%:1.2-28.7), and internal (3.0%:0.3-8.4)/external device (5.8%:0.3-17.4) malfunction were common adverse events.

Conclusions: HNS is a safe and effective treatment for CPAP refractory OSA. Further study comparing HNS to other therapies is required.

Citing Articles

The role of positional changes in optimizing OSA treatment: evidence from DISE.

Mladonova M, Fedorova K, Jor O, Slonkova J, Konde A, Kominek P Eur Arch Otorhinolaryngol. 2025; .

PMID: 40064683 DOI: 10.1007/s00405-025-09314-y.

Effect of norepinephrine reuptake inhibitors combined with antimuscarinic agents vs monotherapy for OSA: a systematic review and meta-analysis.

Wang J, Ye Y, Shang Z, Zheng Q, Zhang S, Li L J Clin Sleep Med. 2024; 20(8):1363-1372.

PMID: 38494994 PMC: 11294128. DOI: 10.5664/jcsm.11130.

Nerve Stimulation for the Treatment of Obstructive Sleep Apnea.

Yamauchi M, Satoh M, Kitahara T, Ota I, Strohl K Sleep Biol Rhythms. 2023; 18:77-87.

PMID: 38031560 PMC: 10686243.

Patient-reported experience with hypoglossal nerve stimulation in the treatment of obstructive sleep apnea.

Braun M, Wollny M, Schoebel C, Sommer J, Heiser C Sleep Breath. 2023; 28(1):221-230.

PMID: 37542679 PMC: 10955022. DOI: 10.1007/s11325-023-02887-0.

MEntA Program Based on Motivational Interview to Improve Adherence to Treatment of Obstructive Sleep Apnea With Continuous Positive Airway Pressure (CPAP): A Randomized Controlled Trial.

Rudilla D, Landete P, Zamora E, Roman A, Vergara I, Ancochea J Open Respir Arch. 2023; 3(2):100088.

PMID: 37497068 PMC: 10369649. DOI: 10.1016/j.opresp.2021.100088.

References

Sterne J, Egger M . Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001; 54(10):1046-55. DOI: 10.1016/s0895-4356(01)00377-8. View

Schwartz A, Bennett M, Smith P, De Backer W, Hedner J, Boudewyns A . Therapeutic electrical stimulation of the hypoglossal nerve in obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 2001; 127(10):1216-23. DOI: 10.1001/archotol.127.10.1216. View

Young T, Palta M, Dempsey J, Peppard P, Nieto F, Hla K . Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. WMJ. 2009; 108(5):246-9. PMC: 2858234. View

Kezirian E, Boudewyns A, Eisele D, Schwartz A, Smith P, Van de Heyning P . Electrical stimulation of the hypoglossal nerve in the treatment of obstructive sleep apnea. Sleep Med Rev. 2010; 14(5):299-305. DOI: 10.1016/j.smrv.2009.10.009. View

Gottlieb D, Yenokyan G, Newman A, OConnor G, Punjabi N, Quan S . Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010; 122(4):352-60. PMC: 3117288. DOI: 10.1161/CIRCULATIONAHA.109.901801. View

Caples S, Rowley J, Prinsell J, Pallanch J, Elamin M, Katz S . Surgical modifications of the upper airway for obstructive sleep apnea in adults: a systematic review and meta-analysis. Sleep. 2010; 33(10):1396-407. PMC: 2941427. DOI: 10.1093/sleep/33.10.1396. View

Ravesloot M, de Vries N . Reliable calculation of the efficacy of non-surgical and surgical treatment of obstructive sleep apnea revisited. Sleep. 2011; 34(1):105-10. PMC: 3001787. DOI: 10.1093/sleep/34.1.105. View

Sawyer A, Gooneratne N, Marcus C, Ofer D, Richards K, Weaver T . A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev. 2011; 15(6):343-56. PMC: 3202028. DOI: 10.1016/j.smrv.2011.01.003. View

Eastwood P, Barnes M, Walsh J, Maddison K, Hee G, Schwartz A . Treating obstructive sleep apnea with hypoglossal nerve stimulation. Sleep. 2011; 34(11):1479-86. PMC: 3198202. DOI: 10.5665/sleep.1380. View

10.

Van de Heyning P, Badr M, Baskin J, Cramer Bornemann M, De Backer W, Dotan Y . Implanted upper airway stimulation device for obstructive sleep apnea. Laryngoscope. 2012; 122(7):1626-33. DOI: 10.1002/lary.23301. View

11.

Mwenge G, Rombaux P, Dury M, Lengele B, Rodenstein D . Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study. Eur Respir J. 2012; 41(2):360-7. DOI: 10.1183/09031936.00042412. View

12.

Rodenstein D, Rombaux P, Lengele B, Dury M, Mwenge G . Residual effect of THN hypoglossal stimulation in obstructive sleep apnea: a disease-modifying therapy. Am J Respir Crit Care Med. 2013; 187(11):1276-8. DOI: 10.1164/rccm.201211-2129LE. View

13.

Kezirian E, Goding Jr G, Malhotra A, ODonoghue F, Zammit G, Wheatley J . Hypoglossal nerve stimulation improves obstructive sleep apnea: 12-month outcomes. J Sleep Res. 2013; 23(1):77-83. PMC: 4323268. DOI: 10.1111/jsr.12079. View

14.

Strollo Jr P, Soose R, Maurer J, de Vries N, Cornelius J, Froymovich O . Upper-airway stimulation for obstructive sleep apnea. N Engl J Med. 2014; 370(2):139-49. DOI: 10.1056/NEJMoa1308659. View

15.

Woodson B, Gillespie M, Soose R, Maurer J, de Vries N, Steward D . Randomized controlled withdrawal study of upper airway stimulation on OSA: short- and long-term effect. Otolaryngol Head Neck Surg. 2014; 151(5):880-7. DOI: 10.1177/0194599814544445. View

16.

Pietzsch J, Liu S, Garner A, Kezirian E, Strollo P . Long-Term Cost-Effectiveness of Upper Airway Stimulation for the Treatment of Obstructive Sleep Apnea: A Model-Based Projection Based on the STAR Trial. Sleep. 2014; 38(5):735-44. PMC: 4402668. DOI: 10.5665/sleep.4666. View

17.

Certal V, Zaghi S, Riaz M, Vieira A, Pinheiro C, Kushida C . Hypoglossal nerve stimulation in the treatment of obstructive sleep apnea: A systematic review and meta-analysis. Laryngoscope. 2014; 125(5):1254-64. DOI: 10.1002/lary.25032. View

18.

Dedhia R, Strollo P, Soose R . Upper Airway Stimulation for Obstructive Sleep Apnea: Past, Present, and Future. Sleep. 2014; 38(6):899-906. PMC: 4434556. DOI: 10.5665/sleep.4736. View

19.

Borenstein M, Hedges L, Higgins J, Rothstein H . A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2015; 1(2):97-111. DOI: 10.1002/jrsm.12. View

20.

Strollo Jr P, Gillespie M, Soose R, Maurer J, de Vries N, Cornelius J . Upper Airway Stimulation for Obstructive Sleep Apnea: Durability of the Treatment Effect at 18 Months. Sleep. 2015; 38(10):1593-8. PMC: 4576333. DOI: 10.5665/sleep.5054. View